Advertisement
AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

AJPH First Look, published online ahead of print May 30, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
AJPH.2007.112342v1
97/7/1161    most recent
Right arrow Submit a response
Right arrow purchase articles
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Get other permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beckwith, C. G.
Right arrow Articles by Flanigan, T. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beckwith, C. G.
Right arrow Articles by Flanigan, T. P.
Related Collections
Right arrow HIV/AIDS
Right arrow Drugs
July 2007, Vol 97, No. 7 | American Journal of Public Health 1161
© 2007 American Public Health Association
DOI: 10.2105/AJPH.2007.112342

LETTER

HIV COUNSELING AND TESTING AMONG INJECTION DRUG USERS NEEDS TO CONTINUE

Curt G. Beckwith, MD, Nickolas Zaller, PhD and Timothy P. Flanigan, MD

Curt G. Beckwith, Nickolas Zaller, and Timothy P. Flanigan are with the Division of Infectious Diseases, the Miriam Hospital and the Warren Alpert Medical School, Brown University, Providence, RI.

Correspondence: Requests for reprints should be sent to Curt G. Beckwith, MD, The Miriam Hospital, 164 Summit Ave, Providence, RI 02906 (e-mail: cbeckwith@lifespan.org).

Because this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

We were interested in the article by Heimer et al.1 that investigated the proportion of injection drug users (IDUs) who were aware and unaware of their HIV serostatus and how this could impact expansion of HIV counseling and testing and prevention efforts. Data from the Centers for Disease Control and Prevention (CDC) have demonstrated a decline in HIV diagnoses attributed to injection drug use, and we recently confirmed a similar decline from 1990 to 2003 in Rhode Island.2,3 Heimer et al. estimated that the number of IDUs unaware of their HIV infection represented a small proportion of the general IDU . . . [Full Text]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Public Health Association